InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 25.06 CNY 0.28%
Market Cap: 21.2B CNY

Intrinsic Value

The intrinsic value of one InnoCare Pharma Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 25.06 CNY, InnoCare Pharma Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

InnoCare Pharma Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
InnoCare Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

InnoCare Pharma Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether InnoCare Pharma Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about InnoCare Pharma Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is InnoCare Pharma Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for InnoCare Pharma Ltd.

Explain Valuation
Compare InnoCare Pharma Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about InnoCare Pharma Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
InnoCare Pharma Ltd

Balance Sheet Decomposition
InnoCare Pharma Ltd

Current Assets 7.8B
Cash & Short-Term Investments 7.3B
Receivables 400m
Other Current Assets 180.3m
Non-Current Assets 1.5B
Long-Term Investments 426m
PP&E 780m
Intangibles 256.1m
Other Non-Current Assets 56.9m
Current Liabilities 1B
Accounts Payable 178m
Accrued Liabilities 96m
Short-Term Debt 80m
Other Current Liabilities 670m
Non-Current Liabilities 1.6B
Long-Term Debt 1.4B
Other Non-Current Liabilities 272m
Efficiency

Free Cash Flow Analysis
InnoCare Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
InnoCare Pharma Ltd

Revenue
1.3B CNY
Cost of Revenue
-174.5m CNY
Gross Profit
1.1B CNY
Operating Expenses
-1.5B CNY
Operating Income
-329.5m CNY
Other Expenses
120.6m CNY
Net Income
-208.9m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

InnoCare Pharma Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative Net Margin
hidden
Profitability
Score

InnoCare Pharma Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

InnoCare Pharma Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
hidden
Solvency
Score

InnoCare Pharma Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
InnoCare Pharma Ltd

Wall Street analysts forecast InnoCare Pharma Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 39.54 CNY with a low forecast of 34.34 CNY and a high forecast of 49.64 CNY.

Lowest
Price Target
34.34 CNY
37% Upside
Average
Price Target
39.54 CNY
58% Upside
Highest
Price Target
49.64 CNY
98% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

InnoCare Pharma Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for InnoCare Pharma Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one InnoCare Pharma Ltd stock?

The intrinsic value of one InnoCare Pharma Ltd stock under the Base Case scenario is hidden CNY.

Is InnoCare Pharma Ltd stock undervalued or overvalued?

Compared to the current market price of 25.06 CNY, InnoCare Pharma Ltd is hidden .

Back to Top